My passion for earth science is part of a broader interest in exploring, learning about, and educating about the earth. For more on my research, see the research and publications tabs. My background is in physics and I am broadly interested in understanding the complex interactions between the elements of the Earth system: the atmosphere, the ocean, the cryosphere, and the land surface. I am also interested in the mechanistic controls on the global ocean overturning circulation and the role of ocean overturning changes in past climate change. I also work on the large-scale atmospheric circulation, its role in the hydrological cycle, and its response to climate change. I am currently focused on understanding the role of the ocean circulation in climate variability on long time scales. By understanding the physical processes controlling the spatial and temporal evolution of climate, I aim to improve our ability to predict climate change and its impacts, so that society can better prepare for the future. I am a climate scientist in the University of Washington Department of Atmospheric Sciences studying the physical basis of climate variability and climate change, specifically the mechanisms governing the large-scale circulation of the atmosphere and ocean. For all of his days, and right up to the end of. He was born in Providence, RI, on November 21, 1931, the son of Raymond and Anna (Cronin) Wills.
#Robert wills instagrid code
Home | Research | Publications | Code | Blog | Photography J., Schneider, T., 2018: Mechanisms setting the strength of orographic Rossby waves across a wide range of climates in a moist idealized GCM. Robert Elmer Wills, 87, of Wolcott, passed away peacefully on January 28, 2019, at St.
Robert JNGLIN WILLS Climate Scientist, University of Washington VP of Manufacturing & Nonclinical Devel.UW - Robert Jnglin Wills - Atmospheric Sciences Sec.Ĭhief Regulatory & Quality Assurance Officer Counsel, Chief Compliance Officer & Corp. Senior Vice President, Chief Scientific Officer President, Chief Executive Officer, Director Because of his more than 35 years of experience in the pharmaceutical industry as an executive focused on research and development, business development and strategic partnering, as well as his corporate governance and board oversight experience, we believe he is able to make valuable contributions to the Board.Ĭymabay Therapeutics Inc executives and stock ownersĬymabay Therapeutics Inc executives and other stock owners filed with the SEC include: in Pharmaceutics from the University of Texas. in Pharmaceutics from the University of Wisconsin and a Ph.D. Wills was previously a member of the board of directors of GTx, Inc., where he served as Executive Chairman and Chair of the Scientific and Development Committee. Wills currently serves on the board of directors of Oncternal Therapeutics, Inc., Parion Sciences, Inc. Wills served as Senior Vice President Global Development at J&J where he was responsible for its late stage development pipeline and was a member of several internal commercial and research and development operating boards. Before assuming his role as Vice President, Alliance Manager at J&J, Dr. Wills spent 22 years in pharmaceutical drug development, 12 of which were at J&J and 10 of which were at Hoffmann-La Roche Inc. Wills served in a variety of executive roles for Johnson & Johnson, or J&J, a medical devices, pharmaceutical and consumer goods manufacturing company, from December 1989 to February 2015 and recently served as Vice President, Alliance Manager where he was responsible for managing strategic alliances for J&J’s Pharmaceutical Group worldwide since 2002.
#Robert wills instagrid series
In February 2020, we wrote a groovy story on the 8.5M Series A and how Sebastian Berning and Andreas Sedlmayr launched their mobile battery startup and met their lead investor SET Ventures at Ecosummit Berlin 2019, our 10-year anniversary. The Instagrid success story continues and reaches the next level. Wills was elected to the Board because of his over 35 years of extensive and significant experience in the pharmaceutical industry, including preclinical and clinical research and development, business development and strategic partnering. Instagrid raises 29M Series B led by Energy Impact Partners. is Independent Chairman of the Board of the Board of the Company.
0 kommentar(er)
